Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →24
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,151
Total Claims
$1.1M
Drug Cost
516
Beneficiaries
$2,042
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-41%
Opioid rate vs peers
1.3% vs 2.2% avg
+45%
Cost per patient vs peers
$2,042 vs $1,411 avg
+66%
Brand preference vs peers
17.6% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.3%
Opioid Rate
187
Opioid Claims
$2,698
Opioid Cost
10.2%
Long-Acting Rate
Brand vs Generic
Brand: 2,482 claims · $784K
Generic: 11,610 claims · $265K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 481 | $167K |
| Dextromethorphan Hbr/Quinidine | 43 | $66K |
| Rivaroxaban | 158 | $53K |
| Insulin Glargine,hum.Rec.Anlog | 142 | $45K |
| Insulin Aspart | 113 | $38K |
| Sitagliptin Phosphate | 97 | $37K |
| Insulin Lispro | 143 | $34K |
| Budesonide/Formoterol Fumarate | 69 | $28K |
| Semaglutide | 19 | $19K |
| Dulaglutide | 17 | $16K |
| Insulin Detemir | 38 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 53 | $15K |
| Tiotropium Bromide | 30 | $15K |
| Ipratropium/Albuterol Sulfate | 30 | $15K |
| Lacosamide | 23 | $14K |
Prescribing Profile
Patient Profile
81
Avg Age
68%
Female
2.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About